Insudive Slim

Home page
Medications
Insudive Slim

Endocrinology

Insudive Slim

Registration certificate:

ЛП-№(010983)-(РГ-RU)

INN:

Semaglutide

Release form:

Solution for subcutaneous injection

Therapeutic Area:

Endocrinology

Pharmacotherapeutic Group:

Hypoglycemic agent – an analogue of glucagon-like peptide-1 (GLP-1)

Conditions for dispensing:

On prescription

Packaging:

Indications and Usage:

Insudive Slim is indicated for use in adult patients over 18 years of age as an adjunct to a low-calorie diet and physical activity to control body weight, including weight loss and maintenance, with an initial body mass index (BMI):

≥ 30 kg/m² (obesity)
≥ 27 kg/m² to 30 kg/m² (overweight) in the presence of at least one overweight-related concomitant disease, such as prediabetes or type 2 diabetes, high blood pressure (hypertension), abnormal blood fat (lipid) levels (dyslipidemia), respiratory disorders during sleep (obstructive sleep apnea syndrome) or cardiovascular diseases.

If there is no improvement or you feel worse, you should consult a doctor.

This product is included in the Essential Drug List (EDL).

Regulatory Status: Rx only.

THERE ARE CONTRAINDICATIONS AND DRUG INTERACTIONS. PLEASE CONSULT A SPECIALIST BEFORE USE.

For the full version of the Insudive Slim (semaglutide) leaflet, please visit this website: https://grls.rosminzdrav.ru/Default.aspx